Evidence map›Paper›PMID 31607568›Full record

ArticleStem cell reports2019

Human Cortical Organoids Expose a Differential Function of GSK3 on Cortical Neurogenesis.

Alejandro López-Tobón, Carlo Emanuele Villa, Cristina Cheroni, Sebastiano Trattaro, Nicolò Caporale, Paola Conforti, Raffaele Iennaco, Maria Lachgar, Marco Tullio Rigoli, Berta Marcó de la Cruz and 9 more

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Modeling cerebral developmentbioRxiv : the preprint server for biology · 2025
    Article
  8. Article
  9. RNA Sequencing Reveals a Strong Predominance ofInternational journal of molecular sciences · 2024
    Article
  10. Article
  11. Article
  12. Science advances · 2023
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 2 countries.

Alejandro López-TobónLaboratory of Stem Cell Epigenetics, IEO, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.
Carlo Emanuele VillaLaboratory of Stem Cell Epigenetics, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
Cristina CheroniLaboratory of Stem Cell Epigenetics, IEO, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.
Sebastiano TrattaroLaboratory of Stem Cell Epigenetics, IEO, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.
Nicolò CaporaleLaboratory of Stem Cell Epigenetics, IEO, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.
Paola ConfortiDepartment of Biosciences, University of Milan, Milan 20133, Italy; Istituto Nazionale di Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan 20122, Italy.
Raffaele IennacoDepartment of Biosciences, University of Milan, Milan 20133, Italy; Istituto Nazionale di Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan 20122, Italy.
Maria LachgarUnidad de Regeneración Neural, Unidad Funcional de Investigación de Enfermedades Crónicas, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Marco Tullio RigoliLaboratory of Stem Cell Epigenetics, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
Berta Marcó de la CruzLaboratory of Stem Cell Epigenetics, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
Pietro Lo RisoLaboratory of Stem Cell Epigenetics, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
Erika TenderiniLaboratory of Stem Cell Epigenetics, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
Flavia TroglioLaboratory of Stem Cell Epigenetics, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
Marco De SimoneIstituto Nazionale di Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan 20122, Italy; Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Isabel Liste-NoyaUnidad de Regeneración Neural, Unidad Funcional de Investigación de Enfermedades Crónicas, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Giuseppe MacinoDepartment of Molecular Medicine, Sapienza Università di Roma, Rome, Italy.
Massimiliano PaganiIstituto Nazionale di Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan 20122, Italy; Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Elena CattaneoDepartment of Biosciences, University of Milan, Milan 20133, Italy; Istituto Nazionale di Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan 20122, Italy.
Giuseppe TestaLaboratory of Stem Cell Epigenetics, IEO, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy. Electronic address: giuseppe.testa@ieo.it.
European Institute of Oncology · ITUniversity of Milan · ITIstituto Nazionale Genetica Molecolare · ITInstituto de Salud Carlos III · ESSapienza University of Rome · ITUnidad Funcional de Investigación de Enfermedades Crónicas · ES

Funding

European Research Council 616441European Research Council 617978
6 · The paper itself

Abstract

The regulation of the proliferation and polarity of neural progenitors is crucial for the development of the brain cortex. Animal studies have implicated glycogen synthase kinase 3 (GSK3) as a pivotal regulator of both proliferation and polarity, yet the functional relevance of its signaling for the unique features of human corticogenesis remains to be elucidated. We harnessed human cortical brain organoids to probe the longitudinal impact of GSK3 inhibition through multiple developmental stages. Chronic GSK3 inhibition increased the proliferation of neural progenitors and caused massive derangement of cortical tissue architecture. Single-cell transcriptome profiling revealed a direct impact on early neurogenesis and uncovered a selective role of GSK3 in the regulation of glutamatergic lineages and outer radial glia output. Our dissection of the GSK3-dependent transcriptional network in human corticogenesis underscores the robustness of the programs determining neuronal identity independent of tissue architecture.

Indexed as

NeurogenesisCell LineCell ProliferationCerebral CortexGene DeletionGlycogen Synthase Kinase 3HumansNeuronsOrganoidsTranscriptomeGlycogen Synthase Kinase 3corticogenesisGSK3human brain organoidsouter radial gliasingle cell transcriptomics

Identifiers

PMID31607568
PMCPMC6893153
OpenAlexW2980036859

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.